Akebia Therapeutics
AKBA
#7744
Rank
S$0.48 B
Marketcap
S$1.81
Share price
-0.35%
Change (1 day)
-35.84%
Change (1 year)

Market capitalization of Akebia Therapeutics (AKBA)

Market cap: S$0.48 Billion

As of April 2026 Akebia Therapeutics has a market cap of S$0.48 Billion. This makes Akebia Therapeutics the world's 7744th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Akebia Therapeutics from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026S$0.48 B-14.41%
2025S$0.56 B-2.2%
2024S$0.57 B87.45%
2023S$0.30 B116.81%
2022S$0.14 B-73.38%
2021S$0.53 B-0.16%
2020S$0.53 B-48.36%
2019S$1.03 B17.4%
2018S$0.88 B-6.07%
2017S$0.94 B62.82%
2016S$0.57 B3.04%
2015S$0.56 B78.86%
2014S$0.31 B

End of Day market cap according to different sources

On Apr 22nd, 2026 the market cap of Akebia Therapeutics was reported to be:

S$0.48 Billion
by Nasdaq info icon info icon
S$0.48 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
S$703.03 B 145,142.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$365.24 B 75,358.16%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
S$240.12 B 49,507.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
S$3.50 B 623.57%๐Ÿ‡บ๐Ÿ‡ธ USA